Elite Pharmaceuticals Inc represents values of innovation, integrity, and excellence in the pharmaceutical industry. The company is committed to developing and commercializing high-quality generic and niche products that meet the needs of patients, healthcare providers, and stakeholders. By focusing on research, development, and manufacturing, Elite Pharmaceuticals Inc ensures the delivery of safe, effective, and affordable medications. With a customer-centric approach, the company strives to improve health outcomes and enhance the overall quality of life. As a leader in the pharmaceutical market, Elite Pharmaceuticals Inc maintains a strong corporate philosophy centered around continuous improvement, ethical behavior, and responsible business practices.

Elite Pharmaceuticals Inc is primarily present in the United States.

Elite Pharmaceuticals Inc has achieved several significant milestones. The company successfully developed and commercialized various generic and niche pharmaceutical products. Elite Pharmaceuticals Inc also forged strategic partnerships with other industry leaders, enabling them to expand their market presence and increase their product offerings. The company has consistently demonstrated its commitment to research and development, resulting in the approval of numerous abbreviated new drug applications (ANDAs) by the FDA. Elite Pharmaceuticals Inc's dedication to innovation and high-quality products has positioned them as a trusted and valuable player in the pharmaceutical industry.

Elite Pharmaceuticals Inc. is a reputable company that has a rich history and background in the pharmaceutical industry. Established in (insert year), Elite Pharmaceuticals Inc. has become a leading player in the field. The company is known for its commitment to innovation and excellence in drug development, manufacturing, and delivery. With a strong focus on research and development, Elite Pharmaceuticals Inc. has successfully developed a diverse portfolio of high-quality and affordable medications. The company's dedication to ensuring the well-being and health of patients has positioned it as a trusted provider in the industry.

The main competitors of Elite Pharmaceuticals Inc in the market include companies such as Teva Pharmaceutical Industries Ltd, Mylan N.V., Sun Pharmaceutical Industries Ltd, Novartis AG, and Johnson & Johnson.

Elite Pharmaceuticals Inc is primarily active in the pharmaceutical industry and specializes in the development, manufacturing, and commercialization of generic and branded pharmaceutical products.

The business model of Elite Pharmaceuticals Inc is focused on developing and commercializing generic and specialty pharmaceutical products. They strive to improve the accessibility and affordability of medications through their innovative formulations and manufacturing capabilities. Elite Pharmaceuticals Inc aims to address unmet medical needs by creating high-quality, cost-effective drug solutions. Their expertise lies in research and development, regulatory affairs, and product commercialization. By consistently delivering superior products and leveraging strategic partnerships, Elite Pharmaceuticals Inc maintains a strong position in the pharmaceutical industry.

Rasio P/E Elite Pharmaceuticals adalah 15,95.

Rasio KUV dari Elite Pharmaceuticals adalah 5,66.

Skor Kualitas AlleAktien untuk Elite Pharmaceuticals adalah 5/10.

Omset Elite Pharmaceuticals adalah 56,63 Juta. USD.

Laba Elite Pharmaceuticals adalah 20,11 Juta. USD.

Elite Pharmaceuticals Inc is an American pharmaceutical company that focuses on the manufacturing, marketing, and development of generics. The company was founded in 1984 by an experienced team of pharmaceutical experts to produce cost-effective and affordable generics. In recent years, Elite Pharmaceuticals Inc has established itself as a key player in the pharmaceutical industry. The company's business model is based on the production and marketing of FDA-approved generics. It has a wide range of products that cover various therapeutic classes such as pain management, muscle relaxants, and psychopharmaceuticals. The company utilizes its proprietary technology called Bioral®, which specializes in the production of oral controlled-release systems and ensures improved bioavailability of active ingredients. Elite Pharmaceuticals Inc operates different business segments to ensure the success of the company. The main business segment is the production and marketing of generics, which form the backbone of the company. The company develops and produces generics in its own facilities in the United States, which adhere to the highest safety and quality standards. Another important business segment of Elite Pharmaceuticals Inc is the research and development of new technologies. The company actively pursues new technologies to enhance the effectiveness of its products and strengthen its position as a key player in the pharmaceutical industry. Elite Pharmaceuticals Inc has partnerships with universities and other companies to further enhance its expertise. As part of the generic manufacturing process, Elite Pharmaceuticals Inc works closely with its distribution partners to place its products in the market. The company has an extensive network of distribution partners that distribute its products in various parts of the United States and beyond. Elite Pharmaceuticals Inc is a continuously growing company committed to providing its customers with high-quality and cost-effective generics. The company constantly strives to expand its product range and develop new technologies to maintain its competitive advantage. Overall, the business model of Elite Pharmaceuticals Inc offers an effective combination of research and development, production and marketing of generics, as well as significant partnerships with pharma-focused companies. The products of Elite Pharmaceuticals Inc have already gained a significant position in the pharmaceutical industry, and the company is well positioned to continue growing and expanding in the future.

Elite Pharmaceuticals membayarkan dividen sebesar 0 USD yang dibagi melalui pembayaran dalam setahun.

Dividen untuk Elite Pharmaceuticals saat ini tidak dapat dihitung atau perusahaan tidak membagikan dividen.

ISIN dari Elite Pharmaceuticals adalah US28659T2006.

WKN dari Elite Pharmaceuticals adalah 634826.

Ticker dari Elite Pharmaceuticals adalah ELTP.

Dalam 12 bulan terakhir, Elite Pharmaceuticals membayar dividen sebesar . Ini setara dengan yield dividen sekitar . Untuk 12 bulan mendatang, Elite Pharmaceuticals diperkirakan akan membayar dividen sebesar 0 USD.

Imbal hasil dividen dari Elite Pharmaceuticals saat ini adalah .

Elite Pharmaceuticals membayar dividen setiap kuartal. Dividen ini dibayarkan pada bulan .

Elite Pharmaceuticals membayar dividen setiap tahun dalam 0 tahun terakhir.

Untuk 12 bulan ke depan, diperkirakan akan ada dividen sebesar 0 USD. Ini setara dengan yield dividen sebesar 0 %.

Elite Pharmaceuticals dikelompokkan dalam sektor 'Kesehatan'.

Untuk menerima dividen terakhir dari Elite Pharmaceuticals tanggal 10/9/2024 sejumlah 0 USD, Anda harus memiliki saham tersebut di portofolio sebelum tanggal Ex-Tag pada 10/9/2024.

Pembayaran dividen terakhir dilakukan pada 10/9/2024.

Pada tahun 2023, Elite Pharmaceuticals 0 USD telah dibayarkan sebagai dividen.

Dividen dari Elite Pharmaceuticals dibayarkan dalam USD.